U.S. -based disease diagnosis start-up PathAI has secured $ 35bn m in a series B funding round led by growth equity company General Atlantic . The latest capital will help the firm to develop its machine learning and AI-powered tools, which aid in the digitising and analysis of pathology images. By offering faster, cheaper and safer sub-typing of diseases like breast cancer, PathAI plans to carve out a market share in the health care cloud computing sector, which is set to be worth $ 60 . The new finance follows an earlier $11m series A funding round, and brings its total venture capital raised to 60 .
Massachusetts-based disease diagnosis start-up PathAI has secured $60m in a series B funding round led by growth equity company General Atlantic. The latest capital will help the firm to develop its machine learning and AI-powered tools, which aid in the digitising and analysis of pathology images. By offering faster, cheaper and safer sub-typing of diseases like breast cancer, PathAI plans to carve out a market share in the health care cloud computing sector, which is set to be worth $35bn. The new finance follows an earlier $11m series A funding round, and brings its total venture capital raised to $75m.